Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9507]

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced...

Dr Mary McCormack - University College Hospital, London, UK

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer ( Dr Mary McCormack - University College Hospital, London, UK )

Active surveillance for oesophageal cancer shows improved HRQoL compared to...

Dr Berend Van der Wilk - Erasmus MC Cancer Institute, Rotterdam, The Netherlands

Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery ( Dr Berend Van der Wilk - Erasmus MC Cancer Institute, Rotterdam, The Netherlands )

Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS...

Dr Filippo Pietrantonio - ‎The National Cancer Institute of Milan, Milan, Italy

Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS G12C-mutated metastatic colorectal cancer ( Dr Filippo Pietrantonio - ‎The National Cancer Institute of Milan, Milan, Italy )

Datopotamab deruxtecan extends PFS vs chemo for HR+/HER2- breast cancer

Dr Aditya Bardia - Mass General Cancer Center, Boston, USA

Datopotamab deruxtecan extends PFS vs chemo for HR+/HER2- breast cancer ( Dr Aditya Bardia - Mass General Cancer Center, Boston, USA )

Adding nivolumab to neoadjuvant chemo improves response rate for high risk ER+...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

Adding nivolumab to neoadjuvant chemo improves response rate for high risk ER+ HER2− breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

Enfortumab vedotin plus pembrolizumab improves overall survival for advanced...

Prof Thomas Powles - Barts Cancer Centre, London, UK

Enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer ( Prof Thomas Powles - Barts Cancer Centre, London, UK )

Belzutifan improves PFS, ORR in clear cell renal cell carcinoma

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

Belzutifan improves PFS, ORR in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC

Dr Michiel Van der Heijden - Netherlands Cancer Institute, Amsterdam...

Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC ( Dr Michiel Van der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )

Effects of short-term fasting on quality of life as an add-on option during...

Dr Daniela Koppold-Liebscher - Charité Universitätsmedizin Berlin, Berlin...

Effects of short-term fasting on quality of life as an add-on option during chemotherapy ( Dr Daniela Koppold-Liebscher - Charité Universitätsmedizin Berlin, Berlin, Germany )

Belzutifan cabozantinib combo shows durable anti-tumour effect at phase II for...

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

Belzutifan cabozantinib combo shows durable anti-tumour effect at phase II for ccRCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Genomic testing: Awareness and effective communication between healthcare...

Prof Richard Simcock and Antonella Cardone

Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )

ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC

Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira

ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC ( Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira )

More from ecancer